A carregar...

Bumetanide for autism: Open‐label trial in six children

AIM: Bumetanide, a diuretic agent, that reduces intracellular chloride—thereby reinforcing GABAergic inhibition—has been reported to improve core symptoms of autism in children. Given the positive results reported from French trials of bumetanide in children with autism, we decided to evaluate its e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Acta Paediatr
Main Authors: Fernell, Elisabeth, Gustafsson, Peik, Gillberg, Christopher
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8248373/
https://ncbi.nlm.nih.gov/pubmed/33336381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apa.15723
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!